Abvc Biopharma (ABVC) Restructuring Costs (2010 - 2012)

Abvc Biopharma (ABVC) has reported Restructuring Costs for 3 consecutive years, with $110305.0 the latest figure, recorded in Q2 2012.

• For the quarter ending Q2 2012, Restructuring Costs fell 80.96% year-over-year to $110305.0; the trailing twelve-month figure through Jun 2012 stood at $760188.0 (down 24.74% YoY), and the FY2011 full-year result was $1.1 million, up 20.18% from the prior year.
• Restructuring Costs declined to $110305.0 in Q2 2012 per ABVC's latest filing, from $210080.0 in the prior quarter.
• Across five years, Restructuring Costs topped out at $579320.0 in Q2 2011 and bottomed at $83743.0 in Q1 2011.
• Historically, Restructuring Costs has averaged $212820.1 across 3 years, with a median of $209027.0 in 2011.
• The sharpest annual moves came in 2011 and 2012: Restructuring Costs soared 299.3% in 2011, then tumbled 80.96% in 2012.
• Over 3 years, Restructuring Costs stood at $211073.0 in 2010, then retreated by 0.97% to $209027.0 in 2011, then plunged by 47.23% to $110305.0 in 2012.
• According to Business Quant data, Restructuring Costs over the past three periods registered $110305.0, $210080.0, and $209027.0 for Q2 2012, Q1 2012, and Q4 2011 respectively.